Drug Profile
Aleglitazar - Roche
Alternative Names: R-1439; RG1439; RO-0728804Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Roche
- Class Antihyperglycaemics; Oxazoles; Propionic acids; Small molecules; Thiophenes
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cardiovascular disorders; Type 2 diabetes mellitus
Most Recent Events
- 10 Jul 2013 Discontinued - Phase-I for Cardiovascular disorders (in volunteers, prevention) in China (PO)
- 10 Jul 2013 Discontinued - Phase-II for Type-2 diabetes mellitus (combination therapy, treatment-experienced) in Germany (PO)
- 10 Jul 2013 Discontinued - Phase-II for Type-2 diabetes mellitus in Hong Kong (PO)